Advancing Biologics Dry-Powder Inhalation: Challenges and Solutions

Time: 10:30 am
day: Day 1


  • Exploring the integration of monoclonal antibodies, vaccines, and therapeutic proteins into Dry Powder Inhalers (DPIs), assessing their suitability and potential benefits for targeted pulmonary delivery
  • Delving into advanced spray drying technologies that optimize the formulation of biologics in DPIs, focusing on maintaining therapeutic integrity and bioactivity
  • Examining methods to enhance the stability of biologic formulations in DPIs, preventing protein aggregation to ensure consistent and effective drug delivery